Evidence-based medicine and cost-effectiveness: Uneasy bedfellows?

Evidence-Based Medicine

Volumn 3, Issue 5, 1998, Pages 133-

  Drummond, Michael ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; MEDICAL ETHICS; SHORT SURVEY;

EID: 0344505786     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. NHS Executive. Improving cost effectiveness. NHS Executive, 1993.
2. Williams A. How should information on cost-effectiveness influence clinical practice? In: Delamothe T, ed. Outcomes in Clinical Practice. London: BMJ Publishing Group; 1994:99-107.
3. Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet. 1997;349:126-8.
4. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2d edition. Oxford: Oxford University Press; 1997.
5. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313: 275-83.
6. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? Ann Intern Med. 1992;116:238-44.
7. Jönsson B. Economic evaluation and clinical uncertainty: response to Freemantle and Maynard. Health Econ. 1994;3:305-7.